126 related articles for article (PubMed ID: 18827986)
1. Methods for evaluation of positive allosteric modulators of glutamate AMPA receptors.
Siuda ER; Quirk JC; Nisenbaum ES
Methods Mol Biol; 2007; 403():37-57. PubMed ID: 18827986
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.
Lees GJ
Drugs; 2000 Jan; 59(1):33-78. PubMed ID: 10718099
[TBL] [Abstract][Full Text] [Related]
3. A novel dualistic profile of an allosteric AMPA receptor modulator identified through studies on recombinant receptors, mouse hippocampal synapses and crystal structures.
Christiansen GB; Harbak B; Hede SE; Gouliaev AH; Olsen L; Frydenvang K; Egebjerg J; Kastrup JS; Holm MM
Neuroscience; 2015 Dec; 310():709-22. PubMed ID: 26450748
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in positive allosteric modulators of the AMPA receptor.
Morrow JA; Maclean JK; Jamieson C
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):571-9. PubMed ID: 17002217
[TBL] [Abstract][Full Text] [Related]
5. [Allosteric modulators of AMPA type glutamate receptors a novel gubclass of physiologically active substances].
Raevskiĭ KS; Eremin KO
Biomed Khim; 2004; 50(6):523-38. PubMed ID: 15707268
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia.
Hagino Y; Kariura Y; Manago Y; Amano T; Wang B; Sekiguchi M; Nishikawa K; Aoki S; Wada K; Noda M
Glia; 2004 Jul; 47(1):68-77. PubMed ID: 15139014
[TBL] [Abstract][Full Text] [Related]
7. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
[TBL] [Abstract][Full Text] [Related]
8. Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors.
Quirk JC; Nisenbaum ES
J Neurosci; 2003 Nov; 23(34):10953-62. PubMed ID: 14645491
[TBL] [Abstract][Full Text] [Related]
9. AMPA receptor potentiators for the treatment of CNS disorders.
O'Neill MJ; Bleakman D; Zimmerman DM; Nisenbaum ES
Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):181-94. PubMed ID: 15180479
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
[TBL] [Abstract][Full Text] [Related]
11. Functional insight into development of positive allosteric modulators of AMPA receptors.
Weeks AM; Harms JE; Partin KM; Benveniste M
Neuropharmacology; 2014 Oct; 85():57-66. PubMed ID: 24878241
[TBL] [Abstract][Full Text] [Related]
12. Affecting AMPA Receptor Biophysical Gating Properties with Negative Allosteric Modulators.
Qneibi M; Hawash M; Jaradat N; Bdir S
Mol Neurobiol; 2022 Sep; 59(9):5264-5275. PubMed ID: 35687302
[TBL] [Abstract][Full Text] [Related]
13. S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.
Lockhart BP; Rodriguez M; Mourlevat S; Peron P; Catesson S; Villain N; Galizzi JP; Boutin JA; Lestage P
Eur J Pharmacol; 2007 Apr; 561(1-3):23-31. PubMed ID: 17331496
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells.
Kreitzer MA; Birnbaum AD; Qian H; Malchow RP
Vis Neurosci; 2009; 26(4):375-87. PubMed ID: 19678977
[TBL] [Abstract][Full Text] [Related]
15. AMPA Receptors as Therapeutic Targets for Neurological Disorders.
Lee K; Goodman L; Fourie C; Schenk S; Leitch B; Montgomery JM
Adv Protein Chem Struct Biol; 2016; 103():203-61. PubMed ID: 26920691
[TBL] [Abstract][Full Text] [Related]
16. Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action.
Arai AC; Xia YF; Rogers G; Lynch G; Kessler M
J Pharmacol Exp Ther; 2002 Dec; 303(3):1075-85. PubMed ID: 12438530
[TBL] [Abstract][Full Text] [Related]
17. Nanoscale Mobility of the Apo State and TARP Stoichiometry Dictate the Gating Behavior of Alternatively Spliced AMPA Receptors.
Dawe GB; Kadir MF; Venskutonytė R; Perozzo AM; Yan Y; Alexander RPD; Navarrete C; Santander EA; Arsenault M; Fuentes C; Aurousseau MRP; Frydenvang K; Barrera NP; Kastrup JS; Edwardson JM; Bowie D
Neuron; 2019 Jun; 102(5):976-992.e5. PubMed ID: 31053408
[TBL] [Abstract][Full Text] [Related]
18. AMPA receptor positive allosteric modulators: a patent review.
Pirotte B; Francotte P; Goffin E; de Tullio P
Expert Opin Ther Pat; 2013 May; 23(5):615-28. PubMed ID: 23405869
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of positive allosteric modulators acting on AMPA receptors.
Jin R; Clark S; Weeks AM; Dudman JT; Gouaux E; Partin KM
J Neurosci; 2005 Sep; 25(39):9027-36. PubMed ID: 16192394
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA.
Ahmed AH; Ptak CP; Oswald RE
Biochemistry; 2010 Apr; 49(13):2843-50. PubMed ID: 20199107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
